Metraipolis › archive › dc_14a554fd241b

A novel dual DYRK1A/B inhibitor for the treatment of type 1 diabetes — Europe PMC PMID:41158127

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41158127
DOI
10.3389/fphar.2025.1657042
License (as archived)
solo-consultazione
Archived
2026-11-09T08:55:40.307Z
SHA-256 of the archived text
df390c85fa6f77d97ce2d94c9bb1cf728cece3ccad860a554487d3689ddf85c3
Stable URL of this page
https://metraipolis.com/documento/dc_14a554fd241b

How to cite

A novel dual DYRK1A/B inhibitor for the treatment of type 1 diabetes — Europe PMC PMID:41158127 — Europe PMC (en), https://europepmc.org/article/MED/41158127 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_14a554fd241b (Metraipolis archive dc_14a554fd241b, sha256 df390c85fa6f77d97ce2d94c9bb1cf728cece3ccad860a554487d3689ddf85c3)
BibTeX
@misc{dc14a554fd241b,
  title = {A novel dual DYRK1A/B inhibitor for the treatment of type 1 diabetes — Europe PMC PMID:41158127},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41158127},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_14a554fd241b; sha256 df390c85fa6f77d97ce2d94c9bb1cf728cece3ccad860a554487d3689ddf85c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41158127. Agents can read the archived copy with the MCP tool read_document.